NEW YORK, November 7, 2024 – Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and ...

Quarter Results07.11.2024 / 12:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Immunic, Inc. Reports Third Quarter 2024 Financial Resultsand Provides Corporate Update– ...

People with celiac disease, lupus, type 1 diabetes, and Sjögren’s syndrome can also be at risk ... Regular follow-up with an endocrinologist is essential to monitor thyroid function and adjust ...

The main treatment for the condition is a strict gluten free diet. According to the FDA, it is safe for those with celiac disease to eat a microscopic amount of the protein, which is why many ...

It's 2024, and it's time to clear up these myths about gluten-free diets and foods. The post Why nutrition experts say you ...

In the fourth quarter of 2024, we expect to announce updated data from the VTP-300 program in ongoing clinical trials in chronic hepatitis B at AASLD – The Liver Meeting® 2024 scheduled from November ...